These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9074692)

  • 41. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiplatelet therapy in the treatment of coronary heart disease.
    Talley JD
    J Ark Med Soc; 1994 Oct; 91(5):241-2. PubMed ID: 7961313
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anticoagulants and antiplatelets].
    Ishikawa K; Nakai S
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1042-50. PubMed ID: 12436656
    [No Abstract]   [Full Text] [Related]  

  • 44. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
    Jneid H; Bhatt DL; Corti R; Badimon JJ; Fuster V; Francis GS
    Arch Intern Med; 2003 May; 163(10):1145-53. PubMed ID: 12767950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
    Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
    Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design.
    Pettersen AA; Seljeflot I; Abdelnoor M; Arnesen H
    Scand Cardiovasc J; 2004 Dec; 38(6):353-6. PubMed ID: 15804802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
    Rajagopal V; Bhatt DL
    Semin Thromb Hemost; 2004 Dec; 30(6):649-55. PubMed ID: 15630671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical practice. Aspirin for primary prevention of coronary events.
    Lauer MS
    N Engl J Med; 2002 May; 346(19):1468-74. PubMed ID: 12000818
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical studies of the effectiveness of aspirin in the prevention of major cardio-cerebrovascular occurrences].
    Mariani M; Biadi O
    Cardiologia; 1995 Dec; 40(12 Suppl 1):423-8. PubMed ID: 8998750
    [No Abstract]   [Full Text] [Related]  

  • 52. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 53. Aspirin for prevention of myocardial infarction and stroke.
    Med Lett Drugs Ther; 1989 Aug; 31(799):77-9. PubMed ID: 2671622
    [No Abstract]   [Full Text] [Related]  

  • 54. Coronary-artery stents--gauging, gorging, and gouging.
    Topol EJ
    N Engl J Med; 1998 Dec; 339(23):1702-4. PubMed ID: 9834311
    [No Abstract]   [Full Text] [Related]  

  • 55. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. When guidelines collide..
    Spencer FA; Becker RC
    Am Heart J; 2004 Mar; 147(3):395-7. PubMed ID: 14999185
    [No Abstract]   [Full Text] [Related]  

  • 57. Aspirin for the primary prevention of coronary events.
    Mascitelli L; Pezzetta F
    N Engl J Med; 2002 Sep; 347(12):948; author reply 948. PubMed ID: 12240692
    [No Abstract]   [Full Text] [Related]  

  • 58. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases.
    Verstraete M
    Drugs; 1991; 42 Suppl 5():22-38. PubMed ID: 1726214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspirin, the poor man's statin?
    Verheugt FW
    Lancet; 1998 Jan; 351(9098):227-8. PubMed ID: 9457087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.